LIPO (Lipella Pharmaceuticals) Net Margin %: 0.00% (As of Sep. 2025)


What is Lipella Pharmaceuticals Net Margin %?

Lipella Pharmaceuticals LIPO +8.43% Net Margin % is 0.00% as of Sep. 2025. The stock has 1 warning sign investors should review. Among 947 Biotechnology companies, Lipella Pharmaceuticals ranks worse than 78.78% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Lipella Pharmaceuticals's Net Income for the three months ended in Sep. 2025 was $-1.25 Mil. Lipella Pharmaceuticals's Revenue for the three months ended in Sep. 2025 was $0.00 Mil. Therefore, Lipella Pharmaceuticals's net margin for the quarter that ended in Sep. 2025 was 0.00%.

The historical rank and industry rank for Lipella Pharmaceuticals's Net Margin % or its related term are showing as below:

LIPO' s Net Margin % Range Over the Past 10 Years
Min: -1411.96   Med: -935.82   Max: -6.44
Current: -994.4

LIPO's Net Margin % is ranked worse than
78.78% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs LIPO: -994.40

Lipella Pharmaceuticals  (OTCPK:LIPO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Lipella Pharmaceuticals Net Margin % Related Terms

Lipella Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Net Margin % Chart

Lipella Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
-6.44 -720.08 -1,411.96 -1,026.44 -935.82

Lipella Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -269.03 0.00 0.00 0.00

LIPO vs WINT, RMTG, CYTOF: Net Margin % Comparison

For the Biotechnology subindustry, Lipella Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipella Pharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipella Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Lipella Pharmaceuticals's Net Margin % falls into.


Lipella Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Lipella Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-5.016/0.536
=-935.82 %

Lipella Pharmaceuticals's Net Margin for the quarter that ended in Sep. 2025 is calculated as

Net Margin=Net Income (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-1.254/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Lipella Pharmaceuticals (LIPO) has a Net Margin % of 0.00% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Lipella Pharmaceuticals and its competitors. According to the industry distribution chart, Lipella Pharmaceuticals ranks #746 out of 947 companies in the Biotechnology industry, placing it in the top 78.8%.
Is Lipella Pharmaceuticals' Net Margin % too high?
Lipella Pharmaceuticals' current Net Margin % is 0.00%. Based on the distribution chart, Lipella Pharmaceuticals ranks #746 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Lipella Pharmaceuticals' Net Margin % compare to WINT and RMTG?
According to the Biotechnology industry distribution chart, Lipella Pharmaceuticals ranks #746 out of 947 companies for Net Margin %. This places Lipella Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Lipella Pharmaceuticals and its competitors. Lipella Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.66, compared to a current price of $0.09 — trading 99% below its estimated fair value. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Net Margin % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.